PD-1 Antibody and JAK1 Inhibitor for Newly Diagnosed Pediatric Hodgikin's Lympoma
Clinical trial NCT07641010 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07641010
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2028-09-30
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.